Agentic AI system may improve rare disease diagnosis  - Takeaways - MDSpire

Agentic AI system may improve rare disease diagnosis 

Higher diagnostic accuracy seen in endocrine system disorders and multisystem conditions.

  • By

  • Matthew Solan

  • April 7, 2026

  • 3 min

Share

  • 1

    DeepRare, an AI system, improved diagnostic accuracy for rare diseases compared to existing tools and physicians.

  • 2

    The system integrates over 40 tools and databases, providing evidence-based reasoning to enhance diagnostic efficiency.

  • 3

    DeepRare achieved higher Recall@1 scores than comparator models, with 69.1% for phenotype and genetic data tasks.

  • 4

    In direct comparisons, DeepRare outperformed experienced physicians, achieving 64% Recall@1 versus 55%.

  • 5

    The system is designed for patients suspected of rare diseases, not for general screening, with noted limitations.

Original Source(s)

Agentic AI system may improve rare disease diagnosis 

  • by Matthew Solan

  • April 7, 2026

Related Content

Rare diseases: FDA proposes new system to therapy approvals

Vitiligo Gets Long-Missing Definitions for Severity and Relapse

A new international consensus framework standardizes how disease severity and relapse are defined, addressing inconsistencies that have complicated clinical trials and treatment decisions.

ALK-positive Spitz nevus of the nasal dorsum in a child: a case report and literature review